International Stem Cell CORP (ISCO) › Operating Cash FlowInternational Stem Cell CORP (ISCO) — Operating Cash FlowAnnual figures by period end, from SEC filings.2010-12-31: -$6.95M2011-12-31: -$6.96M2012-12-31: -$6.69M2013-12-31: -$5.64M2017-12-31: -$2.14M2018-12-31: -$1.08M2019-12-31: -$1.40M2020-12-31: -$341.0K2021-12-31: -$1.30M2022-12-31: $332.0K2023-12-31: $929.0K2024-12-31: $13.0K2025-12-31: $8.0K$8.0K2010-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$8.0K-38.5%2026-03-30From 2025-01-012024-12-31$13.0K-98.6%2026-03-30From 2024-01-012023-12-31$929.0K+179.8%2025-03-28From 2023-01-012022-12-31$332.0K—2024-03-28From 2022-01-012021-12-31-$1.30M—2023-03-30From 2021-01-012020-12-31-$341.0K—2022-03-29From 2020-01-012019-12-31-$1.40M—2021-03-30From 2019-01-012018-12-31-$1.08M—2020-06-01From 2018-01-012017-12-31-$2.14M—2019-04-15From 2017-01-012013-12-31-$5.64M—2014-03-17From 2013-01-012012-12-31-$6.69M—2014-03-17From 2012-01-012011-12-31-$6.96M—2013-03-26From 2011-01-012010-12-31-$6.95M—2012-03-16From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)